CRISPR, the powerful genome-editing tool, does a molecular tango to cut and modify DNA that is highly nuanced. The same subtlety applies to the public’s…
Comments closedCategory: Articles
MilliporeSigma, a subsidiary of pharmaceutical giant Merck KGaA of Darmstadt, Germany, has become a new major player in the complicated European patent battles over CRISPR,…
Comments closedPARIS—An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people…
Comments closed
The University of California (UC) has fired another legal salvo in the prolonged patent battle over CRISPR, the revolutionary gene-editing technology that has spawned a…
Comments closed
PARIS—New data from Swaziland, a tiny country in southern Africa, provide some of the most convincing evidence yet that aggressively ramping up treatment for HIV/AIDS…
Comments closed
A new update on the global HIV/AIDS epidemic offers “scorecards” for countries that starkly highlight successes in green and failures in red (for an example,…
Comments closed
ST. LOUIS, MISSOURI—A few months before completing medical school in 2003, Lukas Wartman was diagnosed with acute lymphoblastic leukemia (ALL), a blood cancer that’s particularly…
Comments closed
As health officials and aid workers head to a remote corner of the Democratic Republic of the Congo to respond to an outbreak of Ebola…
Comments closed
As health officials and aid workers head to a remote corner of the Democratic Republic of the Congo to respond to an outbreak of Ebola…
Comments closed